← Back to patent-cliff list
Envogmilast
Tier C — Watch / tradeEnvogmilast
Dart Neuroscience Llc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PDE4D
Indications (approved)：脆性X染色体综合征, Ischaemic stroke
Regional status
US
Phase II
2025-11-22
EU
Phase II
2025-11-22
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Envogmilast?
Approved indications include: 脆性X染色体综合征, Ischaemic stroke.
When does the Envogmilast patent expire?
No public expiry year is available for Envogmilast yet; this page updates once verified.
How do I get a quote for Envogmilast intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-09